NSB 2.78% 3.7¢ neuroscientific biopharmaceuticals ltd

Ann: EmtinB Can Become a Revolutionary Treatment for Glaucoma, page-33

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 234 Posts.
    lightbulb Created with Sketch. 4
    Regardless of what the short term sp is, this is amazing news if future results show this is as successful in humans, not only will it make us very rich but will be an incredible medical breakthrough as mentioned in the announcement not only would it cure the disease it would reverse the effects, and that would be extremely life changing to a lot of people facing a slow decent into blindness
 
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
(20min delay)
Last
3.7¢
Change
0.001(2.78%)
Mkt cap ! $5.350M
Open High Low Value Volume
3.5¢ 3.7¢ 3.5¢ $8.491K 230.2K

Buyers (Bids)

No. Vol. Price($)
1 8 3.7¢
 

Sellers (Offers)

Price($) Vol. No.
3.8¢ 80000 1
View Market Depth
Last trade - 15.49pm 18/11/2024 (20 minute delay) ?
NSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.